

Features of perception of color stimuli in achromatopsia
https://doi.org/10.33791/2222-4408-2023-3-187-202
Abstract
Introduction. Understanding the peculiarities of perception of color images by patients with achromatopsia helps to identify and differentiate this pathology from diseases with similar clinical symptoms in time. This is becoming increasingly relevant due to ongoing developments in the field of virus vector therapy using an adeno-associated virus carrying the CNGB3 and CNGA3 genes.
Purpose: to investigate the features of perception of color images by patients with achromatopsia, using in addition to the generally accepted developed proprietary tests to quantify the brightness of perceived images.
Materials and methods. Five school-age patients (12–17 years) with complete achromatopsia were observed. The control group included 36 schoolchildren aged from 10 to 17 (av. 13.4 ± 0.5) with a normal state of visual functions. The ophthalmological examination included standard research methods. In children with achromatopsia, OСT data and ERG indicators were taken into account. To study color vision in all children, the following methods were used: E.B. Rabkin’s polychromatic tables, Neitz Test, Farnsworth–Munsell Dichotomodus D-15 Test, a study of the field of vision for white and colored stimuli (on the perimeter of PNR-03). In addition, in children with achromatopsia, the perception of color stimuli with achromatic stimuli was compared using special proprietary images.
Results. Comparison of the results of the study of color vision in patients with achromatopsia in different ways demonstrates the greatest probability of diagnostic errors when using polychromatic tables, which may be due to the ability of these patients to distinguish test figures in some tables based on brightness contrast, rather than contrast of color tones. Increased sensitivity of photoreceptors to short-wave (blue part of the spectrum) radiation and significantly reduced sensitivity to short-wave (red part of the spectrum) in patients with achromatopsia may cause the expansion of the boundaries of the field of view to green and blue stimuli (while the boundaries of the field of view to the blue stimulus almost reach the values for the white stimulus), as well as a significant narrowing to red stimuli compared with the indicators in the control group (p < 0.001). The developed own test images made it possible to quantify the brightness of chromatic stimuli perceived by patients with achromatopsia in comparison with the brightness of achromatic stimuli. The brightest (90–100%) for them was the blue stimulus and practically merged with the white background of the screen. The red stimulus was perceived to be the darkest (minimum brightness). Based on the data obtained, an approximate model of the perception of color images in achromatopsia was created. Conclusion. The obtained data complement the existing ideas about the peculiarities of perception of color images by patients with achromatopsia and can be used to develop new and improve existing methods of diagnosing this disease, as well as to create recommendations for the design of illustrative, educational and advertising material.
About the Authors
S. I. RychkovaRussian Federation
Svetlana I. Rychkova, Cand. Sci. (Med.), Оphthalmologist, Lead researcher of Vision Physiology laboratory, Department of Eye Diseases
19, Bolshoy Karetny Lane, Moscow, 127051
15, Gamalei Str., Moscow, 123098
V. G. Likhvantseva
Russian Federation
Vera G. Likhvantseva, Dr. Sci. (Med.), Professor of the Department of Ophthalmology
91, Volokolamskoye Highway, Moscow, 125371
R. I. Sandimirov
Russian Federation
Roman I. Sandimirov, Studen
1, Ostrovityanovа Str., Moscow, 117997
References
1. Avetisov S.E., Kashchenko T.P., Shamshinova A.M. Visual functions and their correction in children: Guide for physicians. Мoscow: Meditsina; 2005. 872 p. (In Russ.)
2. Hirji N., Aboshiha J., Georgiou M., Bainbridge J., Michaelides M. Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options. Ophthalmic Genet. 2018;39:149–57. https://doi.org/10.1080/13816810.2017.141 8389
3. Abeijon Martinez S.A. Review of achromatopsia. Trends in ophthalmology Open Access Journal. 2020;3(1):222–236. https://doi.org/10.32474/TOOAJ.2020.03.000154
4. Solaki M., Baumann B., Reuter P., Andreasson S., Audo I., Ayuso C. et al. Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia. Human Mutation. 2022;43:832–858. https://doi.org/10.1002/humu.24371
5. Ivanova M.E., Zolnikova I.V., Khatsenko I.E., Strelnikov V.V., Konovalov F.А., Lozier E.R. et al. Characteristics of epidemiology, clinics and pathogenesis of achromatopsia in Russian population. Russian Ophthalmological Journal. 2020;13(1):12– 22. (In Russ.) https://doi.org/10.21516/2072-0076-2020-13-1-12-22
6. Brunetti-Pierri R., Karali M., Melillo P., Di Iorio V., De Benedictis A., Iaccarino G. et al. Clinical and molecular characterization of achromatopsia patients: a longitudinal study. International Journal of Molecular Sciences. 2021;22(4):1681. https://doi.org/10.3390/ijms22041681
7. Barton J.J. Disorders of color and object recognition: syndromes of the ventral occipitotemporal pathway. Continuum: Lifelong Learning in Neurology. 2010;16(4):111–127. https://doi.org/10.1212/01.CON.0000368264.61286.9b
8. Schallhorn C.S., Granet D.B., Ferreyra H.A. Electronegative electroretinogram in achromatopsia. Retinal Cases & Brief Report. 2018;12(2):143–148. https://doi.org/10.1097/ICB.0000000000000451
9. Zolnikova I.V., Rogatina E.V. Method of achromatopsia diagnostics. Patent RU 2444977, 20.03.2012. (In Russ.)
10. Rosenberg T., Olsen J.V., Weisschuh N., Kohl S., Wissinger B. Old mystery solved: achromatopsia, the Fuur genealogy in retrospective. Annals of Case Report. 2021;6:628. https://doi.org/10.29011/2574-7754.100628
11. Baraas R.C., Pedersen H.R., Hagen L.A. Single-cone imaging in inherited and acquired colour vision deficiencies. Current Opinion in Behavioral Sciences. 2019;30:55–59. https://doi.org/10.1016/j.cobeha.2019.05.006
12. Patterson E.J., Langlo C.S., Georgiou M., Kalitzeos A., Pennesi M.E., Neitz J. et al. Comparing retinal structure in patients with achromatopsia and blue cone monochromacy using OCT. Ophthalmology Science. 2021;1(3):100047. https://doi.org/10.1016/j.xops.2021.100047
13. Rabkin E.B. Polychromatic tables for colour perception research. Мoscow: Meditsina; 1971. 72 p. (In Russ.)
14. Yustova E.N., Alekseeva K.A., Volkov V.V., Roslyakov V.А., Sergeev V.P. Set of tables for colour vision testing. Patent RU 2078532, 10.05.1997. (In Russ.)
15. Ishihara S. Tests for colour blindness. Tokyo: Kanehara Shupper Co. Ltd.; 1972.
16. Shamshinova A.M., Volkov V.V. Functional methods of research in ophthalmology. Мoscow: Meditsina; 1999. 414 p. (In Russ.)
17. Rogatina E.V., Golubtsov K.V. Critical frequency of flashings junction in differential diagnostics of visual analyzer pathology in children. Vestnik Oftalmologii. 1997;113(6):20– 22. (In Russ.)
18. Golubtsov K.V., Maksimov V.V., Orlov O.Yu. Computer system for diagnostics of colour perception disturbance in little children. Patent RU 90667, 20.01.2010. (In Russ.)
19. Kay C. Gene therapy updates in achromatopsia. International Ophthalmology Clinics. 2021;61(4):149–155. https://doi.org/10.1097/IIO.0000000000000379
20. Michalakis S., Gerhardt M., Rudolph G., Priglinger S., Priglinger C. Achromatopsia: genetics and gene therapy. Molecular Diagnosis & Therapy. 2022;26(1):51–59. https://doi.org/10.1007/s40291-021-00565-z
21. McKyton A., Averbukh E., Marks Ohana D., Levin N., Banin E. Cortical visual mapping following ocular gene augmentation therapy for achromatopsia. Journal of Neuroscience. 2021;41(35):7363–7371. https://doi.org/10.1523/jneurosci.3222-20.2021
22. Andersen M.K.G., Kessel L. Ametropia and emmetropization in CNGB3 achromatopsia. Investigative Ophthalmology & Visual Science. 2021;62(2):10–10. https://doi.org/10.1167/iovs.62.2.10
23. Neitz M., Neitz J. A new mass screening test for color-vision deficiencies in children. Color Research & Application. 2001;26(1):239–249. https://doi.org/10.1002/1520-6378(2001)26:1+<::aid-col51 > 3.0.co;2-l
24. Makarov I.A. Prevalence of hereditary color perception disorders. Ophthalmology. 2020;17(3):414–421. https://doi.org/10.18008/1816-5095-2020-3-414-421
25. Eckstut A., Eckstut J. What is color? New York: ABRAMS; 2020. 144 p.
26. Omelyanenko E.V. Chromatics and coloristics: Study guide. Saint Petersburg: Lan’, Planeta Muzyki; 2017. 104 p. (In Russ.)
27. Kolb H., Fernandez E., Nelson R. Webvision: The organization of the retina and visual system. Salt Lake City (UT): University of Utah Health Sciences Center; 2020. pp. 979–1022.
28. Kazilek C.J., Cooper K. Rods and cones of the human eye. ASU, Ask A Biologist; 2010.
29. Brown T.M., Gias C., Hatori M., Keding S.R., Semo M., Coffey P.J. et al. Melanopsin contributions to irradiance coding in the thalamo-cortical visual system. PLoS Biol. 2010;8(12):e1000558. https://doi.org/10.1371/journal.pbio.1000558
30. Lockley S.W., Brainard G.C., Czeisler C.A. High Sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. The Journal of Clinical Endocrinology & Metabolism. 2003;88(9):4502–4505. https://doi.org/10.1210/jc.2003-030570
31. Sacks O. Island of the colorblind. Мoscow: АSТ; 2017. 352 p. (In Russ.)
Review
For citations:
Rychkova S.I., Likhvantseva V.G., Sandimirov R.I. Features of perception of color stimuli in achromatopsia. The EYE GLAZ. 2023;25(3):187-202. (In Russ.) https://doi.org/10.33791/2222-4408-2023-3-187-202